Enzymatica AB (publ) Stock

Enzymatica AB (publ) Debt 2024

Enzymatica AB (publ) Debt

9.71 SEK

Ticker

ENZY.ST

ISIN

SE0003943620

WKN

A1WZEV

In 2024, Enzymatica AB (publ)'s total debt was 9.71 SEK, a -134.23% change from the -28.37 SEK total debt recorded in the previous year.

Enzymatica AB (publ) Aktienanalyse

What does Enzymatica AB (publ) do?

Enzymatica AB (publ) is a Swedish healthcare company that specializes in the development, production, and marketing of enzyme technology. It was founded in 2007 and is headquartered in Lund, Sweden. The company is listed on the Nasdaq Stockholm. Enzymatica AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Enzymatica AB (publ)'s Debt Structure

Enzymatica AB (publ)'s total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Enzymatica AB (publ)'s debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Enzymatica AB (publ)’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Enzymatica AB (publ)’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Enzymatica AB (publ) stock

What is the debt of Enzymatica AB (publ) this year?

Enzymatica AB (publ) has a debt level of 9.71 SEK this year.

What was the debt of Enzymatica AB (publ) compared to the previous year?

The debt of Enzymatica AB (publ) has increased by -134.23% compared to the previous year dropped.

What are the consequences of high debt for investors in Enzymatica AB (publ)?

High debt can pose a risk for investors of Enzymatica AB (publ), as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Enzymatica AB (publ)?

Low debt means that Enzymatica AB (publ) has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Enzymatica AB (publ) affect the company?

An increase in debt of Enzymatica AB (publ) can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Enzymatica AB (publ) affect the company?

A reduction in debt of Enzymatica AB (publ) can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Enzymatica AB (publ)?

Some factors that can influence the debt of Enzymatica AB (publ) include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Enzymatica AB (publ) so important for investors?

The debts of Enzymatica AB (publ) are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Enzymatica AB (publ) take to change the debt?

To change the debt, Enzymatica AB (publ) can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Enzymatica AB (publ) pay?

Over the past 12 months, Enzymatica AB (publ) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Enzymatica AB (publ) is expected to pay a dividend of 0 SEK.

What is the dividend yield of Enzymatica AB (publ)?

The current dividend yield of Enzymatica AB (publ) is .

When does Enzymatica AB (publ) pay dividends?

Enzymatica AB (publ) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Enzymatica AB (publ)?

Enzymatica AB (publ) paid dividends every year for the past 0 years.

What is the dividend of Enzymatica AB (publ)?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Enzymatica AB (publ) located?

Enzymatica AB (publ) is assigned to the 'Health' sector.

Wann musste ich die Aktien von Enzymatica AB (publ) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Enzymatica AB (publ) from 9/19/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.

When did Enzymatica AB (publ) pay the last dividend?

The last dividend was paid out on 9/19/2024.

What was the dividend of Enzymatica AB (publ) in the year 2023?

In the year 2023, Enzymatica AB (publ) distributed 0 SEK as dividends.

In which currency does Enzymatica AB (publ) pay out the dividend?

The dividends of Enzymatica AB (publ) are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Enzymatica AB (publ)

Our stock analysis for Enzymatica AB (publ) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Enzymatica AB (publ) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.